Obesity Surgery

, Volume 25, Issue 1, pp 97–108

Cardiovascular Risk Profile in Mediterranean Patients Submitted to Bariatric Surgery and Intensive Lifestyle Intervention: Impact of Both Interventions After 1 Year of Follow-Up

  • Pilar Sanchis
  • Carla Frances
  • Joana Nicolau
  • Rosmeri Rivera
  • Regina Fortuny
  • Xavier Julian
  • Salvador Pascual
  • Luis A. Gomez
  • Irene Rodriguez
  • Josefina Olivares
  • Luisa Ayala
  • Luis Masmiquel
Original Contributions

Abstract

Background

The aim was to compare obesity-related cardiovascular (CV) risk factors (classic and emerging) and the estimated CV risk at 10 years (calculated by REGICOR) in obese Mediterranean patients submitted to bariatric surgery and intensive lifestyle intervention at baseline and after 1 year of follow-up.

Methods

Patients submitted to bariatric surgery (n = 108) and standardized program of therapeutic changes in lifestyle (n = 90) were retrospectively included. Clinical history, physical examination, and laboratory analysis were routinely determined before weight loss intervention and at 1 year follow-up.

Results

Seventy-five percent of the surgery patients had a CV risk lower than 5 % and not one patient had a 10-year CV risk higher than 15 %. The percentage of patients with comorbidities (diabetes and sleep apnea syndrome) was higher in the surgery group. Seventeen of the surgery patients had no comorbidities. The improvement in CV risk profile was significant higher in the surgery group. CV risk benefit of both intervention groups was related to baseline higher CV risk, with type 2 diabetes with poor metabolic control and high cholesterol levels being the most important predictors for surgery patients. Neither body mass index nor excess of weight loss was related to CV risk improvement.

Conclusions

Mediterranean patients undergoing a weight loss intervention have a low CV risk. In comparison with lifestyle intervention, surgery induces a better improvement of CV risk. This benefit is related to estimated CV risk, presence of diabetes, and cholesterol levels at baseline. These observations should be taken into account in order to optimize health resources.

Keywords

Cardiovascular risk profile Bariatric surgery Lifestyle intervention Morbid obesity Type II diabetes Hypercholesterolemia 

References

  1. 1.
    Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355(8):763–78.PubMedCrossRefGoogle Scholar
  2. 2.
    Vest AR, Heneghan HM, Schauer PR, et al. Surgical management of obesity and the relationship to cardiovascular disease. Circulation. 2013;127(8):945–59. doi:10.1161/CIRCULATIONAHA.112.103275.PubMedCrossRefGoogle Scholar
  3. 3.
    Jiang J, Ahn J, Huang WY, et al. Association of obesity with cardiovascular disease mortality in the PLCO trial. Prev Med. 2013;57(1):60–4. doi:10.1016/j.ypmed.2013.04.014.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration BMI Mediated Effects). Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet. 2013. doi:10.1016/S0140-6736(13)61836-X.Google Scholar
  5. 5.
    Must A, Spadano Van Gaal LF, Maggioni AP. Overweight, obesity, and outcomes: fat mass and beyond. Lancet. 2013. doi:10.1016/S0140-6736(13)62076-0.Google Scholar
  6. 6.
    Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363(23):2211–9. doi:10.1056/NEJMoa1000367.PubMedCrossRefGoogle Scholar
  7. 7.
    Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA. 2003;290(7):932–40.PubMedCrossRefGoogle Scholar
  8. 8.
    Tzotzas T, Evangelou P, Kiortsis DN. Obesity, weight loss and conditional cardiovascular risk factors. Obes Rev. 2011;12(5):e282–9. doi:10.1111/j.1467-789X.2010.00807.x.PubMedCrossRefGoogle Scholar
  9. 9.
    Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93. doi:10.1056/NEJMoa035622.PubMedCrossRefGoogle Scholar
  10. 10.
    Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61. doi:10.1056/NEJMoa066603.PubMedCrossRefGoogle Scholar
  11. 11.
    Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65. doi:10.1001/jama.2011.1914.PubMedCrossRefGoogle Scholar
  12. 12.
    Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23. doi:10.1001/jama.299.3.316.PubMedCrossRefGoogle Scholar
  13. 13.
    Hofsø D, Nordstrand N, Johnson LK, et al. Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol. 2010;163(5):735–45. doi:10.1530/EJE-10-0514.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427–36. doi:10.1007/s11695-012-0864-0.PubMedCrossRefGoogle Scholar
  15. 15.
    Aasheim ET, Björkman S, Søvik TT, et al. Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch. Am J Clin Nutr. 2009;90(1):15–22. doi:10.3945/ajcn.2009.27583.PubMedCrossRefGoogle Scholar
  16. 16.
    American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37 Suppl 1:S81–90. doi:10.2337/dc14-S081.CrossRefGoogle Scholar
  17. 17.
    Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133–5. doi:10.2337/dc09-9036.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–52.PubMedCrossRefGoogle Scholar
  19. 19.
    National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–421.Google Scholar
  20. 20.
    Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999 22(5):667-89.Google Scholar
  21. 21.
    Wood D, De Backer G, Faergeman O, et al. Task Force Report. Prevention of coronary heart disease in clinical practice: recommendations of the second joint task force of the joint European Societies on coronary prevention. Eur Heart J. 1998;19(10):1434–503.CrossRefGoogle Scholar
  22. 22.
    Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001 16;285(19):2486-97.Google Scholar
  23. 23.
    Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004;110(2):227–39.PubMedCrossRefGoogle Scholar
  24. 24.
    Anderson KM, Wilson PWF, Odell PM, et al. An updated coronary risk profile. A statement for health professionals. Circulation. 1991;83(1):356–62.PubMedCrossRefGoogle Scholar
  25. 25.
    Wilson PWF, D’Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–47.PubMedCrossRefGoogle Scholar
  26. 26.
    Menotti A, Lanti M, Puddu PE, et al. Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart. Heart. 2000;84(3):238–44.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J. 2000;21(5):365–70.PubMedCrossRefGoogle Scholar
  28. 28.
    Marrugat J, Solanas P, D’Agostino R, et al. Coronary risk estimation in Spain using a calibrated Framingham function. Rev Esp Cardiol. 2003;56(3):253–61.PubMedCrossRefGoogle Scholar
  29. 29.
    Marrugat J, D'Agostino R, Sullivan L, et al. An adaptation of the Framingham coronary risk function to southern Europe Mediterranean areas. J Epidemiol Community Health. 2003;57(8):634–8.PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    Comín E, Solanas P, Cabezas C, et al. Estimating cardiovascular risk in Spain using different algorithms. Rev Esp Cardiol. 2007;60(7):693–702.PubMedCrossRefGoogle Scholar
  31. 31.
    Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham Study. Diabetes Care. 1979;2(2):120–6.PubMedCrossRefGoogle Scholar
  32. 32.
    Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Heneghan HM, Meron-Eldar S, Brethauer SA, et al. Effect of bariatric surgery on cardiovascular risk profile. Am J Cardiol. 2011;108(10):1499–507. doi:10.1016/j.amjcard.2011.06.076.PubMedCrossRefGoogle Scholar
  34. 34.
    Ortega E, Morínigo R, Flores L, et al. Predictive factors of excess body weight loss 1 year after laparoscopic bariatric surgery. Surg Endosc. 2012;26(6):1744–50. doi:10.1007/s00464-011-2104-4.PubMedCrossRefGoogle Scholar
  35. 35.
    Dixon JB, Dixon ME, O'Brien PE. Pre-operative predictors of weight loss at 1-year after Lap-Band surgery. Obes Surg. 2001;11(2):200–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Poirier P, Cornier MA, Mazzone T, et al. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation. 2011;123(15):1683–701. doi:10.1161/CIR.0b013e3182149099.PubMedCrossRefGoogle Scholar
  37. 37.
    Martins C, Strømmen M, Stavne OA, et al. Bariatric surgery versus lifestyle interventions for morbid obesity–changes in body weight, risk factors and comorbidities at 1 year. Obes Surg. 2011;21(7):841–9. doi:10.1007/s11695-010-0131-1.PubMedCrossRefGoogle Scholar
  38. 38.
    Jacobson TA. Lipoprotein (a), cardiovascular disease, and contemporary management. Mayo Clin Proc. 2013;88(11):1294–311. doi:10.1016/j.mayocp.2013.09.003.PubMedCrossRefGoogle Scholar
  39. 39.
    Thompson GR, Seed M. Lipoprotein (a): the underestimated cardiovascular risk factor. Heart. 2013. doi:10.1136/heartjnl-2013-304902.PubMedGoogle Scholar
  40. 40.
    Dixon JB, Dixon ME, O'Brien PE. Elevated homocysteine levels with weight loss after Lap-Band surgery: higher folate and vitamin B12 levels required to maintain homocysteine level. Int J Obes Relat Metab Disord. 2001;25(2):219–27.PubMedCrossRefGoogle Scholar
  41. 41.
    Sugerman HJ, Wolfe LG, Sica DA, et al. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg. 2003;237(6):751–6. discussion 757-8.PubMedCentralPubMedGoogle Scholar
  42. 42.
    Look AHEAD Research Group, Wing RR, Bolin P, Brancati FL, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145–54. doi:10.1056/NEJMoa1212914.PubMedCrossRefGoogle Scholar
  43. 43.
    Gerstein HC. Do lifestyle changes reduce serious outcomes in diabetes? N Engl J Med. 2013;369(2):189–90. doi:10.1056/NEJMe1306987.PubMedCrossRefGoogle Scholar
  44. 44.
    Laakso M. Cardiovascular disease in type 2 diabetes from population to man to mechanisms. Diabetes Care. 2010;33(2):442–9. doi:10.2337/dc09-0749.PubMedCentralPubMedCrossRefGoogle Scholar
  45. 45.
    Edward H, Livingston MD. Inadequacy of BMI as an indicator for bariatric surgery. JAMA. 2012;307(1):88–9. doi:10.1001/jama.2011.1950.CrossRefGoogle Scholar
  46. 46.
    Livingston EH. Pitfalls in using BMI as a selection criterion for bariatric surgery. Curr Opin Endocrinol Diabetes Obes. 2012;19(5):347–51. doi:10.1097/MED.0b013e328357f0b8.PubMedCrossRefGoogle Scholar
  47. 47.
    Shah NR, Braverman ER. Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin. PLoS One. 2012;7(4):e33308. doi:10.1371/journal.pone.0033308.PubMedCentralPubMedCrossRefGoogle Scholar
  48. 48.
    Gómez-Ambrosi J, Silva C, Galofré JC, et al. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond). 2012;36(2):286–94. doi:10.1038/ijo.2011.100.CrossRefGoogle Scholar
  49. 49.
    Gómez-Ambrosi J, Silva C, Catalán V, et al. Clinical usefulness of a new equation for estimating body fat. Diabetes Care. 2012;35(2):383–8.PubMedCentralPubMedCrossRefGoogle Scholar
  50. 50.
    Benaiges D, Goday A, Ramon JM, et al. Laparoscopic sleeve gastrectomy and laparoscopic gastric bypass are equally effective for reduction of cardiovascular risk in severely obese patients at one year of follow-up. Surg Obes Relat Dis. 2011;7(5):575–80. doi:10.1016/j.soard.2011.03.002.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Pilar Sanchis
    • 1
    • 2
  • Carla Frances
    • 1
  • Joana Nicolau
    • 1
  • Rosmeri Rivera
    • 1
  • Regina Fortuny
    • 3
  • Xavier Julian
    • 4
  • Salvador Pascual
    • 4
  • Luis A. Gomez
    • 1
  • Irene Rodriguez
    • 1
  • Josefina Olivares
    • 1
  • Luisa Ayala
    • 1
  • Luis Masmiquel
    • 1
  1. 1.Endocrinology and Nutrition Department, Hospital Son LlàtzerUniversity Institute of Health Sciences Research (IUNICS), Health Research Institute of Palma (IdISPa)Palma de MallorcaSpain
  2. 2.Research Unit, Hospital Son LlàtzerUniversity Institute of Health Sciences Research (IUNICS), Health Research Institute of Palma (IdISPa)Palma de MallorcaSpain
  3. 3.Clinical Laboratory, Hospital Son LlàtzerUniversity Institute of Health Sciences Research (IUNICS), Health Research Institute of Palma (IdISPa)Palma de MallorcaSpain
  4. 4.Surgery Department, Hospital Son LlàtzerUniversity Institute of Health Sciences Research (IUNICS), Health Research Institute of Palma (IdISPa)Palma de MallorcaSpain

Personalised recommendations